Prevention of chemotherapy-induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle

Juha J. Hulmi, Tuuli A. Nissinen, Markus Räsänen, Joni Degerman, Juulia H. Lautaoja, Karthik Amudhala Hemanthakumar, Janne T. Backman, Olli Ritvos, Mika Silvennoinen, Riikka Kivelä

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalJournal of cachexia, sarcopenia and muscle
Volume9
Issue number2
Pages (from-to)417-432
Number of pages16
ISSN2190-6009
DOIs
Publication statusPublished - Apr 2018
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Myostatin
  • Activins
  • Transcriptome
  • p53
  • Doxorubicin
  • Ccl21
  • DOXORUBICIN-INDUCED CARDIOTOXICITY
  • CANCER CACHEXIA
  • TRANSFERRIN RECEPTOR
  • PROTEIN-SYNTHESIS
  • GENE-EXPRESSION
  • IIB RECEPTOR
  • ACTIVIN-A
  • MDX MICE
  • MYOSTATIN
  • FAILURE
  • 3121 Internal medicine

Cite this